French biotech stock soars 25% after new data on experimental medicine
- Posted on June 30, 2026
- By CNBC
- 0 Views
- 1 min read
French biotech stock soars 25% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.